Ironwood Pharmaceuticals | IRWD - Net Income


Ironwood Pharmaceuticals reported $3.19M in Net Income for its fiscal quarter ending in December of 2024.





Net Income Change Date
Acadia Pharmaceuticals USD 71.78M 45.11M Sep/2025
Agios Pharmaceuticals USD -103.43M 8.59M Sep/2025
Almirall EUR 26.58M 31.82M Jun/2025
Alnylam Pharmaceuticals USD 251.08M 317.36M Sep/2025
Amarin USD -7.74M 6.4M Sep/2025
Ardelyx USD -969K 18.11M Sep/2025
Astellas Pharma JPY 100.38B 21.17B Dec/2025
AstraZeneca USD 2.53B 83M Sep/2025
Charles River Laboratories USD 54.42M 2.1M Sep/2025
Exact Sciences USD -19.59M 18.41M Sep/2025
Halozyme Therapeutics USD 175.22M 10.06M Sep/2025
Incyte USD 424.17M 19.17M Sep/2025
Ironwood Pharmaceuticals USD 3.19M 457K Dec/2024
MacroGenics USD 16.82M 53.07M Sep/2025
Moderna USD -200M 625M Sep/2025
Myriad Genetics USD -27.4M 303.1M Sep/2025
Pacira USD 5.43M 10.28M Sep/2025
PTC Therapeutics USD 15.9M 80.75M Sep/2025
Sarepta Therapeutics USD -179.95M 376.84M Sep/2025
Takeda JPY 103.64B 115.44B Dec/2025
Ultragenyx Pharmaceutical USD -180.41M 65.46M Sep/2025